Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Frequent Involvement of PVT1 in Multiple Myeloma Carrying 8q24 Rearrangement and Identification of Novel PVT1-NBEA Chimeric Gene,

Hisao Nagoshi, MD, Tomohiko Taki, MD, PhD, Ichiro Hanamura, MD, PhD, Masakazu Nitta, MD, PhD, Takemi Otsuki, MD, PhD, Kazuhiro Nishida, MD, PhD, Keiko Okuda, MD, PhD, Natsumi Sakamoto, Satoru Kobayashi, Mio Yamamoto, MD, Yasuhiko Tsutsumi, MD, Tsutomu Kobayashi, MD, PhD, Yosuke Matsumoto, MD, PhD, Shigeo Horiike, MD, PhD, Junya Kuroda, MD, PhD, Masafumi Taniwaki, MD, PhD

Blood (2011) 118 (21): 3917.

https://doi.org/10.1182/blood.V118.21.3917.3917

Published: 2011

Journal Articles

Identification and Functional Significance of Novel Type of Structurally Aberrant Transcripts of DCC In B-Cell Malignancies.

Hisao Nagoshi, MD, Tomohiko Taki, MD, PhD, Junya Kuroda, MD, PhD, Kazuhiro Nishida, MD, PhD, Minako Gotoh, Keiko Okuda, MD, PhD, Satoru Kobayashi, Mio Yamamoto, MD, Yasuhiko Tsutsumi, MD, Tsutomu Kobayashi, MD, Yosuke Matsumoto, MD, PhD, Shigeo Horiike, MD, PhD, Takemi Otsuki, MD, PhD, Masafumi Taniwaki, MD, PhD

Blood (2010) 116 (21): 3623.

https://doi.org/10.1182/blood.V116.21.3623.3623

Published: 2010

Journal Articles

Alterations of DCC Gene in B-Cell Malignancies.

Hisao Nagoshi, Tomohiko Taki, Kazuhiro Nishida, Minako Goto, Satoru Kobayashi, Yasuhiko Tsutsumi, Yosuke Matsumoto, Junya Kuroda, Shigeo Horiike, Takemi Otsuki, Masafumi Taniwaki

Blood (2009) 114 (22): 4428.

https://doi.org/10.1182/blood.V114.22.4428.4428

Published: 2009

Journal Articles

NK4, an antagonist of hepatocyte growth factor (HGF), inhibits growth of multiple myeloma cells: molecular targeting of angiogenic growth factor

Wenlin Du, Yutaka Hattori, Taketo Yamada, Kunio Matsumoto, Toshikazu Nakamura, Morihiko Sagawa, Takemi Otsuki, Takako Niikura, Toshihiro Nukiwa, Yasuo Ikeda

Blood (2006) 109 (7): 3042–3049.

https://doi.org/10.1182/blood-2006-02-003103

Published: 2006

Journal Articles

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells

Ennio Carbone, Paola Neri, Maria Mesuraca, Mariateresa T. Fulciniti, Takemi Otsuki, Daniela Pende, Veronika Groh, Thomas Spies, Giuditta Pollio, David Cosman, Lucio Catalano, Pierfrancesco Tassone, Bruno Rotoli, Salvatore Venuta

Blood (2005) 105 (1): 251–258.

https://doi.org/10.1182/blood-2004-04-1422

Published: 2005

Journal Articles

NK4, an Antagonist of Hepatocyte Growth Factor (HGF), Inhibits Growth of Multiple Myeloma Cells In Vitro and In Vivo : A Mouse Model for Molecular Targeting of Angiogenic Growth Factor.

Yutaka Hattori, MD, Wenlin Du, PhD, Taketo Yamada, MD, Kunio Matsumoto, PhD, Toshikazu Nakamura, MD, Takemi Otsuki, MD, Takako Niikura, PhD, Toshihiro Nukiwa, MD, Yasuo Ikeda, MD

Blood (2004) 104 (11): 637.

https://doi.org/10.1182/blood.V104.11.637.637

Published: 2004

Journal Articles

Role for Interleukin-6 and Insulin like Growth Factor-I Via PI3-K/Akt Pathway in the Proliferation of CD56-Negative and Positive Multiple Myeloma Cells.

Naohi Sahara, Akihiro Takeshita, Miki Kobayashi, Kazuyuki Shigeno, Satoki Nakamura, Kaori Shinjo, Kensuke Naito, Takemi Otsuki, Kazunori Ohnishi, Ryuzo Ohno

Blood (2004) 104 (11): 3365.

https://doi.org/10.1182/blood.V104.11.3365.3365

Published: 2004

Journal Articles

Concurrent activation of a novel putative transforming gene, myeov , and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32)

Johannes W. G. Janssen, Jan-Willem Vaandrager, Tanja Heuser, Anna Jauch, Philip M. Kluin, Erik Geelen, P. Leif Bergsagel, W. Michael Kuehl, Hans G. Drexler, Takemi Otsuki, Claus R. Bartram, Ed Schuuring

Blood (2000) 95 (8): 2691–2698.

https://doi.org/10.1182/blood.V95.8.2691

Published: 2000

Journal Articles

A Novel Chromosomal Translocation t(4; 14)(p16.3; q32) in Multiple Myeloma Involves the Fibroblast Growth-Factor Receptor 3 Gene

Raffaella Richelda, Domenica Ronchetti, Luca Baldini, Lilla Cro, Luigi Viggiano, Rosalia Marzella, Mariano Rocchi, Takemi Otsuki, Luigia Lombardi, Anna Teresa Maiolo, Antonino Neri

Blood (1997) 90 (10): 4062–4070.

https://doi.org/10.1182/blood.V90.10.4062

Published: 1997

NARROW

Frequent Involvement of PVT1 in Multiple Myeloma Carrying 8q24 Rearrangement and Identification of Novel PVT1-NBEA Chimeric Gene,

Identification and Functional Significance of Novel Type of Structurally Aberrant Transcripts of DCC In B-Cell Malignancies.

Alterations of DCC Gene in B-Cell Malignancies.

NK4, an antagonist of hepatocyte growth factor (HGF), inhibits growth of multiple myeloma cells: molecular targeting of angiogenic growth factor

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells

NK4, an Antagonist of Hepatocyte Growth Factor (HGF), Inhibits Growth of Multiple Myeloma Cells In Vitro and In Vivo : A Mouse Model for Molecular Targeting of Angiogenic Growth Factor.

Role for Interleukin-6 and Insulin like Growth Factor-I Via PI3-K/Akt Pathway in the Proliferation of CD56-Negative and Positive Multiple Myeloma Cells.

Concurrent activation of a novel putative transforming gene, myeov , and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32)

A Novel Chromosomal Translocation t(4; 14)(p16.3; q32) in Multiple Myeloma Involves the Fibroblast Growth-Factor Receptor 3 Gene

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only